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Background: The aim of this study is to evaluate the response to the non-surgical treatment of peri-implant mucosi-
tis using the diode laser as an adjuvant therapy in patients with implant-supported restorations, in terms of clinical 
variables, with respect to those patients in whom conventional non-surgical therapy is used.
Material and Methods: Randomized controlled clinical trial with simple blind 3 months follow-up. Two groups 
of patients were established, the non-surgical mechanical debridement of the affected implants was performed in 
the control group (n = 34) and the diode laser therapy was also performed in the test group (n = 34). The implant 
was considered the study subject; the variables considered were plaque index, bleeding on probing depth, depth of 
probing and recession of the peri-implant mucosa. The t-Student test was used to establish the intergroup statistical 
differences and the analysis of variance (ANOVA) was used to measures intragroup differences over time.
Results: In the revaluation at 6 weeks, we observed statistically significant differences (p <0.05) between the va-
riables of plaque index and depth of probing between both groups. The test group obtained an average of 0.248 ± 
0.3155 in plaque index and 0.833 ± 0.374mm in the depth of probing compared to the results obtained in the control 
group that was 0.558 ± 0.526 and 1,137 ± 0.222mm respectively. In the 3-month reevaluation, was also obtained 
great statistical significance between both groups for bleeding on probing (p <0.001), with values of 0.568 ± 0.282 
for the control group and 0.480 ± 0.336 for the test group.
Conclusions: The use of diode laser as an adjunctive therapy to the conventional treatment of peri-implant mucosi-
tis showed promising results, being more effective reducing the inflammation of the peri-implant tissue, positioning 
itself as a valuable tool for the treatment of peri-implant pathologies.
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Introduction
Since the 1990s, implantology has established as a new 
surgical discipline of dentistry (1). Nowadays treatment 
with dental implants in patients with total or partial eden-
tulism is considered a predictable surgical-prosthodontic 
procedure, however, is not exempt from mechanical and 
biological complications (2). 
Biological complications include peri-implant patho-
logies, defined as the inflammatory processes that take 
place in the tissues surrounding an implant (3). Two en-
tities are distinguished: peri-implant mucositis and peri-
implantitis. According to the latest definition provided 
by the “Consensus report from 2017 World Workshop 
on Periodontology”, peri-implant mucositis is defined 
as an inflammatory process, which develops with ede-
ma and bleeding at probing at 30 seconds, induced by 
dental biofilm with absence of loss of bone after bone 
remodeling (1,4).
Peri-implant pathologies have an increasing prevalence. 
In Spain, the last review carried out by Rodrigo D et al. 
in 2018 showed a prevalence of 51% for peri-implant 
pathologies, with a mucositis rate of 27% (5). Interna-
tionally, the most recent review carried out by Derks 
& Tomasi in 2015 showed a prevalence of 65% for pe-
ri-implant pathologies with 43% of patients affected by 
mucositis (6).
Due to the high prevalence of these pathologies, especia-
lly peri-implant mucositis, there are numerous treatment 
strategies. The most common is a non-surgical approach, 
by mechanical debridement of the affected implants with 
plastic curettes (7). However, this conventional treatment 
has limitations in the resolution of peri-implant mucositis 
(8,9). To overcome these limitations, different adjuvant 
therapies have emerged over the years, diode laser the-
rapy being introduced very recently. Recent studies have 
observed that diode laser acts on two fronts, against bio-
film, the main etiological factor involved in peri-implant 
mucositis, through bacterial decontamination and also in 
the regeneration of peri-implant tissues through the pro-
cess of cell biostimulation (10, 11).
Therefore, the hypothesis of this study considers that dio-
de laser can provide additional clinical benefits to the con-
ventional non-surgical therapy of peri-implant mucositis. 
The main objective of this study is to evaluate the res-
ponse to non-surgical treatment of peri-implant muco-
sitis through the use of diode laser as an adjunctive the-
rapy in patients with implant-supported rehabilitation, 
in terms of clinical variables, respect to patients where 
conventional therapy is used. 
Material and Methods
-Study design 
A randomized controlled, single blind, prospective 
3-month clinical study was carried out. The design of 
this study was performed using the CONSORT Declara-
tion 2010 as a guide for conducting randomized clinical 
trials of parallel groups (12).
- Participants
In this study, 68 patients with peri-implant mucositis 
who attended the Master of Advanced Oral Implanto-
logy of the European University of Valencia during 
the months of January to May 2019 were evaluated. 
The study protocol was supervised and approved by 
the Ethics Committee of the Research of the European 
University and by the Scientific Committee of the San 
Carlos Clinical Hospital in Madrid. All patients received 
an informed consent the day of the baseline visit that 
specified the objective of the study, the possible benefits 
and risks derived from the intervention, as well as their 
free participation in the study. All consents were given 
to the patients at least 24 hours before the treatment and 
were explained in detail by the researcher (RS). 
The following inclusion criteria were considered: Pa-
tients over 18 years of age, periodontally healthy with 
unitary screwed implant-supported prostheses with pe-
ri-implant mucositis were included. According to the la-
test World Workshop on Periodontology of 2017, those 
implants that presented edema and bleeding on probing 
at 30 seconds with absence of bone loss were diagnosed 
with mucositis. The absence of bone loss was verified 
by comparing a parallel radiograph performed in the 
delivery of the prosthesis and a new one made at the 
baseline visit.
Patients with cemented unit prostheses or multiple pros-
theses were excluded. In the same way patients with 
immunological systemic diseases, who took chronic 
non-steroidal anti-inflammatory drugs or who had recei-
ved antibiotics in the 6 months prior to the start of the 
study were excluded. Patients who had received non-sur-
gical peri-implant treatment in the previous 6 months or 
surgery in the previous 12 months and patients irradiated 
in the head and neck area were also excluded.
- Interventions
Patients who accomplish the inclusion criteria and vo-
luntarily agreed to participate in the study (n=68) were 
divided into two groups. The control group (n=34) recei-
ved conventional non-surgical treatment of peri-implant 
mucositis and the test group (n=34) received in addition 
diode laser therapy.
Conventional non-surgical treatment
All patients (n = 68) received conventional non-surgical 
treatment following the protocol proposed by Renvert et 
al. in 2008 (7). The implant crown was removed, mecha-
nical debridement was performed with plastic curettes 
(Implant Deplaquers®, KerrHawe SA, Bioggio, Switzer-
land) and with PH1 plastic ultrasound tip (Acteon Sate-
lec®, Acteon Medical-Dental Iberian SAU, Barcelona, 
Spain). The peri-implant sulcus was irrigated with 0.12% 
chlorhexidine + 0.05% cetylpyridinium chloride (Pe-
rio-Aid Treatment®, Dentaid, Barcelona, Spain) (Fig. 1).
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Diode laser therapy
Patients in the test group (n = 34) received, in addition to 
conventional non-surgical treatment, Fox® diode laser 
therapy (A.R.C. Laser GmbH, Nürnberg, Germany) dis-
tributed by Sweden & Martina (Mediterranea SL, Padua, 
Italy). It was used with a wavelength of 810 nm, power 
of 1 watt in pulsed mode and for 30 seconds per surface. 
First, the diffuser tip of 1 cm in diameter was applied 
and then the 300μ tip was used in the peri-implant sulcus 
parallel to the implant axis for 30 seconds (Figure 1).
-Results
Once the informed consent was signed and received in-
formation about the objective of the study, the medical 
and sociodemographic variables of the sample were co-
llected. Including: Age, gender, medical history, aller-
gies, toxic habits, marital status, level of studies and type 
of profession
A preliminary calibration trial was performed for the cli-
nical variables, in which 10 patients with peri-implant 
mucositis, not related with the study, were involved per-
forming a complete periodontal examination in a dupli-
cate manner within 2 weeks. The inter-class correlation 
coefficient of agreement of 0.91 was obtained.
Fig. 1: Images of the clinical protocol. Conventional non-surgical treatment of peri-implant mucositis (A, 
B, C): A) Removal of the crown to expose the peri-implant sulcus, B) Mechanical debridement with plastic 
curette, C) Mechanical debridement with plastic ultrasound tip. Diode laser therapy (D, E): D) Application of 
the diffuser tip, E) Application of the 300 μ optical fiber tip.
One investigator (RS) recorded the plaque index (PI), 
bleeding on probing (BoP), probing pocket depth 
(PPD), and recession of the peri-implant mucosa (REC) 
at 4 locations per implant (mesio-vestibular, vestibular, 
disto-vestibular and palatine) using periodontal probe 
(North Caroline Probe, Hu-Friedy, Leinmen, Germany).
The primary outcomes were PI BoP that were transfor-
med from categorical to quantitative variables, the rest 
of clinical variables and also sociodemographic and me-
dical variables were considered as secondary outcomes.
- Sample size
The sample size was calculated in order to detect a BoP 
reduction (considered as a primary outcome variable) of 
20% with a standard deviation (SD) of 0.96 assuming 
an alpha risk of 0.05 with a 95% of power; the resulting 
figure was a desirable sample of 28 implants per group 
(13). Taking into account possible drop-outs, the total 
calculation of patients in the study was based on an addi-
tional 20%. Therefore, a sample size of 34 implants per 
group is established.
- Randomization, allocation concealment, implementa-
tion and masking mechanism
The principal investigator (SA) was in charge of rando-
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mizing the groups, using a randomized system based on 
stratified blocks depending on whether the patients were 
smokers or not. The allocation concealment was carried 
out through the use of sealed opaque envelopes, which 
were opened by a researcher (RS) during the non-surgi-
cal therapy of peri-implant mucositis. The interventions 
assigned to each group were performed by a calibrated 
and trained examiner, not blind to the group assignment 
(RS). The principal investigator (SA) performed the sta-
tistical analysis of the data and remained blinded after 
the assignment of the interventions
- Statistical methods
The implant was considered as the unit of analysis. The 
homogeneity of the study groups was established using 
the t-Student test for the age variable and the χ2 test for 
the rest of the socio-demographic and medical variables. 
All clinical variables were expressed in means with stan-
dard deviation (SD). For the intragroup differences the 
ANOVA test was used and also for the intergroup diffe-
rences the t-Student test was used. Data were analyzed 
(Statistical Package for Social Sciences for MAC, SPSS 
Inc., Chicago, IL, USA) and the level of statistical signi-
ficance was set at 5% (p <0.05) for all analysis.
Results
Out of the 181-screened implants, 68 were included in 
the study. The implants belonged to a total of 68 pa-
tients, with a mean age of 57±11.39 years. One hundred 
and twelve implants were excluded because they did 
not fulfill the inclusion criteria, one patient refused to 
participate in the study and there was a loss in the test 
group during the 6-week follow-up phase (Fig. 2).  All 
Fig. 2: Flow-chart of the study, with number of patients.
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implants included in the study were conical implants, 
with internal connection and unitary screwed prosthe-
ses. Most of the implants were 3i (n= 62) (BIOMET 3i 
T3®, Zimmer Biomet, Indiana, USA) and the rest were 
Straumann implants (n=6) (Straumann BL®, Straumann 
GmbH, Freiburg, Germany). The implants were in func-
tion for an average time of 3,057 ± 1.49 years. 
- Sociodemographic and medical data.
The sociodemographic and medical data of the patients 
are summarized in Tables 1 and 2 respectively. The sam-









Age (Years) 54.7±10,46 59.16±12,09 57±11.39 0.253*
p>0.05
Gender Men 14 26 40 0.027¥
p<0.05Women 20 8 28
Civil status Single 8 2 10 0.066¥
p>0.05Married 10 20 30
Widower 6 10 16
Separated 10 2 12
Schooling Basic 10 10 26 0.155¥
p>0.05High school 14 4 18
Professional training 2 6 8
Degree 8 8 16
Employment Status Hired hand 20 16 36 0.388¥
p>0.05Self-employment 6 2 8
Housewife 8 2 2
Retired 0 10 18
Unemployed 0 4 4








Systemic disease Yes 28 12 40 0.006*
p<0.05No 6 22 28
Drugs Yes 24 14 38 0.092¥
p>0.05No 10 20 30
Allergies Yes 28 30 58 0.658¥
p>0.05No 6 4 10
Tobacco Non smoker 24 20 44 0.140¥
p>0.05Smoker 6 2 8
Former smoker 4 12 16
ple was homogeneous because most of the variables pre-
sent a non-statistically significant intergroup difference 
(p> 0.05).
- Results of the clinical parameters
•Plaque Index (PI)
The control group (CG) presented at baseline a mean 
plaque value of 0.676 ± 0.374, 0.588 ± 0.526 in the reva-
luation at 6 weeks and 0.509 ± 0.370 at 3 months. On the 
other hand, the test group (TG) presented at the baseline 
visit a value of 0.824 ± 0.541, 0.248 ± 0.3155 at 6 weeks 
Table 1: Sociodemographic characteristics of the sample.
* Statistical test used: t-Student
¥ Statistical test used: Chi-Square test 
Table 2: Medical characteristics of the sample.
* Statistical test used: t-Student
¥ Statistical test used: Chi-Square test 
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and 0.480 ± 0.336 at 3 months. Statistically significant 
differences were observed at 95% (t-Student p = 0.041) 
between the two study groups at the time of the revalua-
tion visit at 6 weeks (Table 3).
•Bleeding on Probing Depth (BoP)
The GC presented an average baseline bleeding rate of 
1.176 ± 0.700, 0.264 ± 0,220 at 6 weeks and 0.568 ± 
0.282 at 3 months. On the other hand, the TG presented 
a value of 1.175 ± 0.795, 0.148 ± 0.150 at 6 weeks and 
Intragroup differences*




Baseline - 6 
weeks 
6 weeks - 3 
months
































Table 3: Plaque index and bleeding on probing variables during the study.
PI: Plaque index; BoP: Bleeding on probing; CG: Control group, TG: Test group. 
* Statistical test used: ANOVA 
i Statistical test used: t-Student
0.264 ± 167 at 3 months. Statistically significant diffe-
rences were observed at 95% (t-Student p = 0.001) be-
tween the two study groups at the time of the 3-month 
revaluation visit (Table 3). Figure 3 shows the behavior 
of this variable throughout the study.
•Probing pocket depth
The CG presented at baseline a mean probing pocket 
depth value of 1.303 ± 0.409mm, 1.137 ± 0.222mm in 
the revaluation at 6 weeks and 1.166 ± 0.263mm at 3 
Fig. 3: Behavior of the variable of bleeding on probing (BoP) during the study. Statistically significant difference 
(p<0.001). * Statistical test used: t-Student.
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months. On the other hand, the TG presented at the base-
line visit a value of 1.277 ± 0.347mm, 0.833 ± 0.374mm 
at 6 weeks and 1.068 ± 0.103mm at 3 months. Statistica-
lly significant differences were observed at 95% (t-Stu-
dent p = 0.041) between the two study groups at the time 
of the revaluation visit at 6 weeks (Table 4).
Intragroup differences*






6 weeks - 3 
months
















































Table 4: Probing pocket depth, recession and clinical attachment level variables during the study. 
PPD: Probing pocket depth; BoP: Bleeding on probing; REC: Recession; CAL: Clinical attachment level; CG: Control group, TG: Test 
group
* Statistical test used: ANOVA 
i Statistical test used: t-Student
•Recession
The CG presented at baseline a mean recession value 
of 0.029 ± 0.065mm, at the 6-week revaluation 0.156 
± 0.253mm and 0.058 ± 0.116mm at 3 months. On the 
other hand, the TG presented at the baseline visit a value 
of 0.018 ± 0.053mm, 0.175 ± 0.289mm at 6 weeks and 
0.107 ± 249mm at 3 months. There were no statistically 
significant differences at 95% in the behavior of this va-
riable throughout the study (Table 4).
Discussion
The results of the present study show that those patients 
who underwent diode laser therapy as an adjunctive ele-
ment to the conventional treatment of mucositis (test 
group), showed less bleeding at 3 months revaluation 
than those patients who only received conventional the-
rapy (p <0.001). The control group also showed worse 
results in the rest of the clinical variables, however these 
differences were not statistically significant (p> 0.05).
- Plaque index 
Once the oral hygiene instructions were given, it was ob-
served that in the reevaluation at 6 weeks the test group 
had shown more improvement in the reduction of the 
plaque index (p <0.05). However, at 3 months both study 
groups returned to present similar biofilm values. These 
results agree with those obtained by the Aimetti et al. in 
2019, which shows an improvement in the plaque index 
for both groups significantly (p <0.001) but without di-
fferences between them at the 3-month revaluation (14).
The fact that both study groups improve plaque in-
dex values is mainly due to oral hygiene instructions 
offered by researchers to patients. The decrease at 6 
weeks seems to be due to the bio-stimulation effect of 
the diode laser, which by facilitating the formation of 
epithelial sealing reduces plaque retention. However, 
patients tend to demotivate over time, which results in 
a greater accumulation of biofilm in the revaluation at 
3 months (14).
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- Bleeding on probing 
In our study, both groups improve significantly in blee-
ding on probing values (p <0.001), obtaining statistical 
significance between both groups in the revaluation at 3 
months (p <0.001). Other studies such as Lerario et al. 
and Al-Amri et al. also obtained statistically significant 
differences (p <0.05) in the decrease in bleeding at pro-
bing between both study groups (13,15), these studies 
were those with the longest follow-up time (12 mon-
ths). On the other hand, studies with shorter follow-up 
times do not observe differences in bleeding at probing 
between both study groups, despite having statistically 
significant differences in plaque index. In our study, the 
difference between bleeding at probing in the test group 
and the control group was increasing according to the 
follow-up time, regardless of the increase in plaque in-
dex.
Aoki et al. reported in their review that several types of 
lasers, including diode laser, have bactericidal proper-
ties. Due to their photothermal effect, the bacteria are 
evaporated, destroyed or denatured by the effect of the 
laser, which results in their devitalization or inactiva-
tion (16,17). These bactericidal properties together with 
biostimulation mechanism reduce the inflammation of 
the peri-implant tissues (18,19).
- Probing pocket depth
Both groups improved in their probing pocket depth me-
asurements (p <0.05). However, the test group showed 
greater improvement than the control group, being this 
difference at the 6-week revaluation statistically signifi-
cant (p <0.05). Nevertheless, at 3-month revaluation the 
measurements increased slightly, obtaining better results 
for the test group but without statistical differences. Au-
thors such as Al-Amri et al. and Aimetti et al. obtained 
similar results in their studies (14,15). In these studies, 
as in ours, plaque indexes were balanced between both 
study groups, this increase in plaque index makes epi-
thelial seal formation difficult, causing, despite the effect 
of the laser, slight changes in the probing pocket depth.
- Recession
The peri-implant mucosal recession increased slightly 
in both study groups, but without statistically significant 
differences at any time during the study (p <0.05). Pre-
vious studies such as Deppe et al. or Thierbach et al. 
also reported increases in mucosal recession after the 
application of the diode laser (20,21). When the inflam-
mation decreases, so does the edema of the tissues and 
with a smaller volume the true loss of mucosal insertion 
is evidenced (22).
Various limitations must be taken into account in this 
study. The published scientific literature on the topic is 
very limited. In addition, the studies differ in the defi-
nition of peri-implant mucositis, the non-surgical treat-
ment applied to the control group and the diode laser 
protocol. All this makes it difficult to compare our re-
sults with those obtained in the rest of the studies. Fina-
lly, only clinical variables were taken into account, more 
studies are needed that approach the issue from a micro-
biological and immunological point of view, in order to 
be able to evaluate the true potential of the diode laser in 
the treatment of peri-implant pathologies.
Therefore, with the limitations of this study, the hypo-
thesis that the diode laser can bring additional clinical 
benefits to conventional non-surgical therapy of pe-
ri-implant mucositis is accepted. A better response of 
the gingival index was obtained, especially in bleeding 
on probing, which avoids a significant decrease of the 
inflammation in the peri-implant tissues, showing a new 
line of research in the application of new technologies in 
the treatment of the peri-implant pathologies. 
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